{"text": "<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> Activates <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> Signaling and Deregulates the <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> Cell Cycle Pathway", "event": "<extra_id_0> <extra_id_1>"}
{"text": "<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transformation of rodent fibroblasts requires activation of PI3K and <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> [ 5 ] .", "event": "<extra_id_0> <extra_id_0> Positive_regulation requires <extra_id_1> <extra_id_0> Theme activation <extra_id_1> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_1>"}
{"text": "Additionally , activated <extra_id_0> pAkt <extra_id_2> Protein <extra_id_1> is frequently detected in NPC and the neoplastic Reed-Sternberg cells of classical HD [ 39 , 40 ] .", "event": "<extra_id_0> <extra_id_0> Positive_regulation activated <extra_id_1> <extra_id_0> Theme pAkt <extra_id_1> <extra_id_1>"}
{"text": "To determine if <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> signaling is activated in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic mice , <extra_id_0> pAkt <extra_id_2> Protein <extra_id_1> and several of its targets were assessed by immunoblotting of splenic <extra_id_0> CD19 <extra_id_2> Protein <extra_id_1> + MACS-purified B cells .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic B cells had increased levels of <extra_id_0> pAkt <extra_id_2> Protein <extra_id_1> compared to wild-type lymphocytes ; however , progression to lymphoma in both <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> - positive and - negative lymphoma cells did not further increase <extra_id_0> pAkt <extra_id_2> Protein <extra_id_1> levels .", "event": "<extra_id_0> <extra_id_0> Positive_regulation increased <extra_id_1> <extra_id_0> Theme pAkt <extra_id_1> <extra_id_0> Positive_regulation increase <extra_id_1> <extra_id_0> Theme pAkt <extra_id_1> <extra_id_1>"}
{"text": "The <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> target <extra_id_0> glycogen synthase kinase 3 <extra_id_2> Protein <extra_id_1> ( <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> ) is inactivated by phosphorylation ; however , increased phosphorylated <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples ( Figure 6A ) .", "event": "<extra_id_0> <extra_id_0> Binding target <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Theme glycogen synthase kinase 3 <extra_id_1> <extra_id_0> Negative_regulation inactivated <extra_id_1> <extra_id_0> Theme target <extra_id_1> <extra_id_0> Positive_regulation increased <extra_id_1> <extra_id_0> Theme phosphorylated <extra_id_1> <extra_id_0> Phosphorylation phosphorylated <extra_id_1> <extra_id_0> Theme GSK3 <extra_id_1> <extra_id_1>"}
{"text": "This finding indicates that <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> is not a target of activated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> in the <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells .", "event": "<extra_id_0> <extra_id_0> Binding target <extra_id_1> <extra_id_0> Theme GSK3 <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Positive_regulation activated <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_1>"}
{"text": "Similarly , activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> without phosphorylation of <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> has been previously shown in EBV - positive HD [ 40 ] .", "event": "<extra_id_0> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Phosphorylation phosphorylation <extra_id_1> <extra_id_0> Theme GSK3 <extra_id_1> <extra_id_1>"}
{"text": "In contrast , the wild-type lymphocytes lacked activated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> but did have detectable phosphorylated <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> .", "event": "<extra_id_0> <extra_id_0> Positive_regulation activated <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Phosphorylation phosphorylated <extra_id_1> <extra_id_0> Theme GSK3 <extra_id_1> <extra_id_1>"}
{"text": "This further suggests that additional pathways are involved in the regulation of <extra_id_0> GSK3 <extra_id_2> Protein <extra_id_1> .", "event": "<extra_id_0> <extra_id_0> Regulation regulation <extra_id_1> <extra_id_0> Theme GSK3 <extra_id_1> <extra_id_1>"}
{"text": "To identify other potential <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> targets , immunoblot analysis for <extra_id_0> p-mTOR <extra_id_2> Protein <extra_id_1> was performed .", "event": "<extra_id_0> <extra_id_0> Binding targets <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_1>"}
{"text": "Activated <extra_id_0> p-mTOR <extra_id_2> Protein <extra_id_1> was not increased in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes or lymphoma cells , indicating that this pathway is not affected by <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> - induced <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activation and does not contribute to lymphoma development ( Figure 6B ) .", "event": "<extra_id_0> <extra_id_0> Positive_regulation Activated <extra_id_1> <extra_id_0> Theme p-mTOR <extra_id_1> <extra_id_0> Positive_regulation increased <extra_id_1> <extra_id_0> Theme Activated <extra_id_1> <extra_id_0> Regulation affected <extra_id_1> <extra_id_0> Theme Activated <extra_id_1> <extra_id_0> Cause induced <extra_id_1> <extra_id_0> Positive_regulation induced <extra_id_1> <extra_id_0> Theme activation <extra_id_1> <extra_id_0> Cause LMP1 <extra_id_1> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_1>"}
{"text": "<extra_id_0> Akt <extra_id_2> Protein <extra_id_1> is also known to phosphorylate and induce the degradation of the pro-apoptotic Forkhead family of transcription factors , leading to cell cycle progression and survival in some human tumors [ 41 , 42 ] .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Immunoblot analysis of splenic B cells did not consistently detect p - <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> levels , a signal that targets <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> for degradation .", "event": "<extra_id_0> <extra_id_0> Regulation targets <extra_id_1> <extra_id_0> Theme FoxO1 <extra_id_1> <extra_id_1>"}
{"text": "Hence , degradation of <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> was assessed by detection of total <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> levels .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Immunoblot analysis indicated that total <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> levels were greatly decreased in wild-type and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphomas ( Figure 6B ) , suggesting that inhibition of the Forkhead signaling pathway is an important target of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> in lymphoma development .", "event": "<extra_id_0> <extra_id_0> Negative_regulation decreased <extra_id_1> <extra_id_0> Theme FoxO1 <extra_id_1> <extra_id_1>"}
{"text": "However , considering that <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activation did not induce <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> degradation in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic B cells , <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> may not be the sole regulator of <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> , and it may be that progression to lymphoma requires modulation of multiple pathways .", "event": "<extra_id_0> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Positive_regulation induce <extra_id_1> <extra_id_0> Theme degradation <extra_id_1> <extra_id_0> Cause activation <extra_id_1> <extra_id_0> Negative_regulation degradation <extra_id_1> <extra_id_0> Theme FoxO1 <extra_id_1> <extra_id_0> Regulation regulator <extra_id_1> <extra_id_0> Theme FoxO1 <extra_id_1> <extra_id_0> Cause Akt <extra_id_1> <extra_id_1>"}
{"text": "The Forkhead family of transcription factors is known to induce the expression of the Cdk inhibitor <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> [ 43 , 44 ] .", "event": "<extra_id_0> <extra_id_0> Gene_expression expression <extra_id_1> <extra_id_0> Theme p27 <extra_id_1> <extra_id_1>"}
{"text": "<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> - transformed rodent fibroblasts have decreased expression of <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> , upregulation of <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_1> , and subsequent phosphorylation and inactivation of the tumor suppressor gene <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> [ 45 ] .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "To investigate whether <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> affected cell cycle regulation through the <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> pathway in B cells , immunoblot analyses for <extra_id_0> pRb <extra_id_2> Protein <extra_id_1> , <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_1> , and <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> were performed on splenic <extra_id_0> CD19 <extra_id_2> Protein <extra_id_1> + MACS-purified B cells .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic B cells had enhanced levels of <extra_id_0> pRb <extra_id_2> Protein <extra_id_1> with concomitant stabilization of total <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> levels and <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_1> compared to wild-type B lymphocytes ( Figure 6C ) .", "event": "<extra_id_0> <extra_id_0> Positive_regulation enhanced <extra_id_1> <extra_id_0> Theme Cdk2 <extra_id_1> <extra_id_0> Positive_regulation enhanced <extra_id_1> <extra_id_0> Theme pRb <extra_id_1> <extra_id_1>"}
{"text": "Progression to lymphoma in both wild-type and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphoma cells led to increased levels of <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> , correspondingly high levels of <extra_id_0> Cdk2 <extra_id_2> Protein <extra_id_1> , and decreased levels of <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> ( Figure 6C ) .", "event": "<extra_id_0> <extra_id_0> Positive_regulation led <extra_id_1> <extra_id_0> Theme increased <extra_id_1> <extra_id_0> Positive_regulation increased <extra_id_1> <extra_id_0> Theme Rb <extra_id_1> <extra_id_0> Positive_regulation high levels <extra_id_1> <extra_id_0> Theme Cdk2 <extra_id_1> <extra_id_0> Negative_regulation decreased <extra_id_1> <extra_id_0> Theme p27 <extra_id_1> <extra_id_1>"}
{"text": "These data indicate that the <extra_id_0> Rb <extra_id_2> Protein <extra_id_1> pathway is deregulated in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and that lymphoma cells are distinguished by loss of <extra_id_0> FoxO1 <extra_id_2> Protein <extra_id_1> and decreased <extra_id_0> p27 <extra_id_2> Protein <extra_id_1> .", "event": "<extra_id_0> <extra_id_0> Negative_regulation loss <extra_id_1> <extra_id_0> Theme FoxO1 <extra_id_1> <extra_id_0> Negative_regulation decreased <extra_id_1> <extra_id_0> Theme p27 <extra_id_1> <extra_id_1>"}
